This result indicates that DME may suppress AChE activity and increase ACh levels in the scopolamine-treated cognitive impaired mice, and attributes, at least in part, to the tendency of cognitive improvement with the treatment of DME. This evidence concerns the gene ACHE and Cognitive impairment.